New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 9, 2012
08:41 EDTAVNR, IPXLAvanir sues Impax over planned Nuedexta generic, Bloomberg reports
Avanir Pharmaceuticals (AVNR) is suing Impax Laboratories (IPXL) for allegedly infringing a new patent for the drug Nuedexta and planning to market a generic version of the drug before the patent expires in 2023, reported Bloomberg, citing a complaint filed in a federal court in Delaware. Reference Link
News For AVNR;IPXL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 24, 2014
10:35 EDTIPXLHigh option volume stocks
Subscribe for More Information
06:26 EDTAVNRAvanir 18.2M share Secondary priced at $11.00
Subscribe for More Information
September 23, 2014
06:12 EDTAVNRStocks with implied volatility below IV index mean; RAX AVNR
Subscribe for More Information
September 22, 2014
18:18 EDTAVNROn The Fly: After Hours Movers
Subscribe for More Information
16:41 EDTAVNRAvanir files automatic mixed securities shelf
11:02 EDTAVNROptions with decreasing implied volatility
Subscribe for More Information
06:17 EDTAVNRAvanir implied volatility of 91 at lower end of index mean range
Subscribe for More Information
September 17, 2014
09:06 EDTIPXLImpax granted extension of Rytary FDA review date to January 9, 2015
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use